The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
11:21
Bulgaria withdraws its military support for Ukraine and makes any financial aid conditional on the funds being used for civilian purposes
11:10
The NetChoicee Association is challenging in court the New York law that requires warnings about the risks of excessive social media use
11:00
Authorities raided a factory in Illinois, USA, after receiving a threat deemed credible regarding the presence of an explosive device
10:51
Iran claims a drone attack on a U.S. base in Bahrain
10:45
Kaja Kallas calls on Israel to protect civilians in Gaza and allow unhindered access for humanitarian aid
See more news